University of Pennsylvania

About University of Pennsylvania

The University of Pennsylvania (commonly referred to as Penn or UPenn) is a private, Ivy League, research university located in Philadelphia. Incorporated as The Trustees of the University of Pennsylvania, Penn is one of 14 founding members of the Association of American Universities and one of the nine original Colonial Colleges. Penn claims to be the oldest university in the United States of America, and is consistently ranked as one of the world's most prestigious universities.

Reviewers: 119

44th in USA

Reviews: 1174

44th in USA

Merit: 3438

44th in USA

Openness: 1.2

129th in USA

Journal Editors at University of Pennsylvania

Reviewers from University of Pennsylvania

  • Reviewer

    Yune-Sang Lee

    I'm a postdoctoral fellow at the university of Pennsylvania's neurology department.

  • Reviewer

    Stephen I Hudis

    Private Practice/ Prosthodontics/Princeton, NJ Associate Clinical Professor University of Pennsylvania School of Dental Medicine

  • Reviewer

    Alexey Rakov

    looking for a new position...

  • Reviewer

    Gregory Way

    Greg is a PhD Candidate in Casey Greene's lab at The University of Pennsylvania. He is in the Genomics and Computational Biology program and is interested in cancer genomics, data integration, and machine learning. See more at

  • Reviewer

    Ronny Drapkin

    The Drapkin laboratory focuses on developing a comprehensive understanding of the genetic, molecular and physiological factors that drive the development of cancer, with a special focus on gynecologic malignancies. Recent work from our group and others has implicated the fallopian tube (FT) secretory cell as the likely cell-of-origin for a majority of high-grade serous ovarian carcinomas. This new concept of ovarian tumorigenesis has been a paradigm shift in the field and the Drapkin lab has been at the forefront in developing novel experimental platforms that address the role of the FT epithelium and its susceptibility to neoplastic transformation. These platforms include genetically engineered mouse (GEM) models, fallopian tube-derived cell lines, and patient-derived tumor xenografts. The lab is currently focused on utilizing these models to interrogate how genetic and epigenetic alterations influence lineage dependencies, genomic instability, DNA repair, replicative stress, and metabolism. The goal is to define selective vulnerabilities that can guide novel therapeutic approaches and biomarker development.

  • Reviewer

    Stacey Humphries

    I'm a postdoc at the University of Pennsylvania working with Anjan Chatterjee. My current projects focus on metaphors, and how they are understood by various types of neurological patients (neurodegenerative, and focal lesion).